M. Groenen

Heterodimeric analogues of the potent Y1R antagonist 1229U91, lacking one of the pharmacophoric C-terminal structures, retain potent Y1R affinity and show improved selectivity over Y4R.

N. Holliday, S. Briddon, P. Thompson, 2020, Journal of medicinal chemistry.

Thyroid-stimulating monoclonal antibodies.

J. Sanders, J. Jeffreys, H. Depraetere, 2002, Thyroid : official journal of the American Thyroid Association.

Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon‐γ

A. Billiau, H. Heremans, C. Dillen, 1996, European journal of immunology.

Role of Interferon- γ and Nitric Oxide in Pulmonary Edema and Death Induced by Lipopolysaccharide

A. Billiau, H. Heremans, C. Dillen, 2000 .

Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imaging.

Lei Zhang, H. Herzog, N. Holliday, 2014, Organic & biomolecular chemistry.

Optically Pure, Structural, and Fluorescent Analogues of a Dimeric Y4 Receptor Agonist Derived by an Olefin Metathesis Approach.

N. Holliday, P. Thompson, S. Mountford, 2016, Journal of medicinal chemistry.

Investigation of mechanisms of protein induced satiety: meal structure and protein content effects on gastric emptying and gut hormone release

G. Holtrop, A. Johnstone, F. Gribble, 2017, Proceedings of the Nutrition Society.

The Arginine of the DRY Motif in Transmembrane Segment III Functions as a Balancing Micro-switch in the Activation of the β2-Adrenergic Receptor

T. Schwartz, T. Frimurer, N. Holliday, 2012, The Journal of Biological Chemistry.